About 1 100 reports

  • INFLUENZA VACCINE MARKET IN APAC
  • MARKET OPPORTUNITY BY VACCINE TYPE

About Influenza Vaccine Influenza is an infectious disease caused by the influenza virus. It is also known as flu. Influenza virus is a ribonucleic acid (RNA) virus that belongs to Orthomyxoviridae family. It is a helical shaped, single-stranded virus. Influenza A virus affects people of all age groups and causes...

  • Vaccine
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Seqirus UK Limited
  • INACTIVATED VACCINES
  • DENGUE VACCINE MARKET IN APAC

About Dengue Vaccine The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemorrhagic...

  • Vaccine
  • World
  • Forecast
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • 8.1 TRANSFORMATION OF VACCINE TECHNOLOGIES
  • 9.4 REDUCING THE TIMELINE FOR VACCINE DEVELOPMENT

The global influenza vaccines market is anticipated to exceed US$ 5.8 Billion mark by 2024, and is presenting ample opportunities to the industry’s players. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets,...

  • Vaccine
  • World
  • Forecast
  • Market Size
  • Sanofi S.A.
  • Combination vaccines
  • Competitive factors

About Veterinary Clostridium Vaccine Clostridium bacteria are widely found in soil and the guts of various animals. These microbes are anaerobic in nature and produce a wide range of toxins leading to various diseases in animals. Some of these diseases are zoonotic in nature. Vaccines play a major role in protecting the animals...

  • Vaccine
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • Merial Limited
  • Zoetis Inc.
  • Vaccine type
  • HUMAN COMBINATION INACTIVATED VACCINES

About Human Combination Vaccines A vaccine is made up of inactive, partially killed or dead viruses, to stimulate the immune system against the pathogenic virus and produce antibodies against it. Vaccines are injected or orally administered. Animal vaccines provide immunity to the animal body against pathogens. They are composed...

  • Infectious Disease
  • Vaccine
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Sanofi S.A.
  • DNA vaccine
  • Vaccine type

About Veterinary Vaccines Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock products...

  • Vaccine
  • Boehringer Ingelheim GmbH
  • Elanco
  • Merck & Co., Inc.
  • Merial Limited
  • Vaccine Adjuvant Market: Revenue in USD million, by Mechanism of Action,
  • Vaccine Adjuvant Market: Revenue in USD million, by Mechanism of Action,

Vaccine Adjuvants Market Adjuvants have been used for decades to improve the immune response to vaccine antigens. They improve the body’s immune response and often allow for smaller amounts of an inactivated virus or bacteria to be used in a vaccine. However, more than one adjuvant may be present in the final vaccine product. Aluminum...

  • Vaccine
  • United States
  • Boehringer Ingelheim Vetmedica, Inc.
  • Brenntag AG
  • Novavax, Inc.
  • 8.1 TRANSFORMATION OF VACCINE TECHNOLOGIES
  • 9.4 REDUCING THE TIMELINE FOR VACCINE DEVELOPMENT

The global influenza vaccines market is anticipated to reach nearly US$ 5 Billion by 2022. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness...

  • Influenza
  • Vaccine
  • World
  • Forecast
  • Market Size
  • Conventional vaccines
  • Emergency vaccines

About Foot and Mouth Disease Vaccine FMD is a severe and contagious viral disease found in cloven-hoofed animals. FMD virus leads to illness in cows, sheep, pigs, goats, deer, and other animals with divided hooves. Animals with FMD will have fever and blisters on the tongue, lips, mammary glands, in and around the mouth, and...

  • Vaccine
  • Forecast
  • Market Size
  • Boehringer Ingelheim GmbH
  • Merck & Co., Inc.
  • VACCINE RECOMMENDATIONS
  • VACCINE MERGERS & ACQUISITIONS

Global Vaccines Market to reach US$ 60 Billion by the year 2022. Pediatric vaccines market is having a dominant market share compared to Adult vaccines market. By 2022 Pediatric vaccines market share will be double the size of adult vaccines market share. Worldwide the number of infants immunized by influenza vaccines remain considerably low...

  • Vaccine
  • World
  • Forecast
  • Meningococcal group
  • Pfizer Inc.
  • Europe HPV Vaccine Market
  • Canada HPV Vaccine Market

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global HPV Vaccine Market by End-User (Male and Female), By Age-Group (Adolescent and Adults), By Region...

  • Therapy
  • Vaccine
  • World
  • Market Size
  • GlaxoSmithKline plc
  • VACCINES
  • SEASONAL INFLUENZA VACCINES MARKET

PharmaPoint: Seasonal Influenza Vaccines - Global Drug Forecast and Market Analysis to 2025 Summary Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses designated as influenza types A, B, and C. The infection’s rapid onset and potential for high morbidity and...

  • Vaccine
  • Market Size
  • CSL Limited
  • Daiichi Sankyo Company
  • Mitsubishi Corporation
  • Influenza Vaccines
  • Global Influenza Vaccines Market By Vaccine Type

Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Influenza Market on the basis of Segment Type (Vaccine and Drugs), By Vaccine (Trivalent and Quadrivalent),...

  • Vaccine
  • World
  • Market Size
  • Emergent BioSolutions Inc.
  • Sanofi S.A.
  • Pneumococcal vaccine market in Americas
  • Inadequate vaccine coverage

About Pneumococcus Pneumococcus (Streptococcus pneumoniae), a pathogenic bacterium, is the leading cause of serious illness worldwide. It is the major cause of pneumonia, blood infections, meningitis, sinusitis, and middle ear infections (otitis media). Pneumococcal infections affect children younger than five years and older people...

  • Vaccine
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • 10.6 VACCINE SHORTAGES AND DELAYS
  • 10.7 OBSTACLES IN VACCINE RESEARCH AND DEVELOPMENT

The adult vaccines market has been forecasted to increase at a compound annual growth rate (CAGR) of around 6% over the next five years. Adults are as likely as children to die from diseases that they can be immunized. For example, vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related...

  • Vaccine
  • Demand
  • Forecast
  • Market Size
  • bioCSL Inc.
  • INTRAMUSCULAR VACCINES
  • INTRADERMAL VACCINES

About the H1N1 Vaccines Market The high level of maturity in the H1N1 vaccines market has renewed the push to develop quadrivalent vaccines that address areas of the market with unmet medical needs. Vaccines that prevent H1N1 have been a long-standing void in the treatment algorithm. Therefore, the introduction advanced vaccines in...

  • Vaccine
  • World
  • AstraZeneca PLC
  • Novartis AG
  • Sanofi S.A.
  • TYPHOID VACCINES
  • POLIO VACCINES

Executive Summary Surging old age population, rising polluted drinking water, development of bioterrorism combined with rising technological development in vaccine industry, growing awareness towards individual health along with initiative taken by various government and non-government institutions have been driving the demand...

  • Vaccine
  • World
  • Market Size
  • Merck & Co., Inc.
  • Sanofi S.A.
  • VACCINE
  • TYPES OF VACCINES

The global market for human vaccines experienced strong growth through 2015. Through 2022, growth will be fueled by continued new product introductions, indication expansions for some products and rising usage, particularly in South America, Europe, India and China. Vaccines: The World Market examines the market for vaccines used in humans...

  • Vaccine
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • 7.1 TRANSFORMATION OF VACCINE TECHNOLOGIES
  • and type B present in the vaccine. Afluria Influenza vaccine was launched in United States in

The influenza vaccines market in Americas is anticipated to reach nearly US$ 3 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly...

  • Vaccine
  • GlaxoSmithKline plc
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.
  • 1.2 INFLUENZA VACCINE
  • SUPPLY CHAIN OF INFLUENZA VACCINE

Influenza, also known as flu, is a contagious disease which spreads from person to person very rapidly. When an infected person sneezes or coughs the virus spreads to those close by, affecting immuno-compromised patients the most. The influenza virus is broadly classified as influenza A, influenza B, and influenza C. The influenza vaccine...

  • Vaccine
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi S.A.
  • 7.1 TRANSFORMATION OF VACCINE TECHNOLOGIES
  • and type B present in the vaccine. Afluria Influenza vaccine was launched in United States in

The European influenza vaccines market is anticipated to reach nearly US$ 650 Million by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly...

  • Vaccine
  • Market Size
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.
  • 10.6 VACCINE SHORTAGES AND DELAYS
  • 9.6 TRANSFORMATION OF VACCINE TECHNOLOGIES

The growing awareness about the importance of child healthcare and well-being is driving the market for pediatric vaccines globally. Pediatric vaccine continues to be one of the booming segment for the pharmaceutical companies. Pediatric vaccines are used in the prevention of numerous diseases, such as Hepatitis- A and -B. Measles, Influenza,...

  • Vaccine
  • Demand
  • Market Size
  • bioCSL Inc.
  • GlaxoSmithKline plc
  • Overview of Vaccines
  • Vaccine Futures

China’s demand for Vaccines has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and...

  • Vaccine
  • China
  • Market Size
  • Supply
  • Shenzhen Kangtai Biological Products Co.
  • Seasonal Influenza Vaccine Market
  • Registered Six Vaccines List

Global Influenza Vaccine Market is worth more than US$ 5 Billion. Globally Pediatrics Influenza Vaccinated Population was more than 150 Thousand, but still this figure was significantly less than the Adult Influenza Vaccinated Population. As per our research Pediatrics Influenza Vaccinated population will decline in future and Adult Influenza...

  • Influenza
  • Vaccine
  • Northern Europe
  • Forecast
  • Market Size
  • 7.1 TRANSFORMATION OF VACCINE TECHNOLOGIES
  • VACCINES AND FORECAST (2011 - 2021)

The Asia and Australasia influenza vaccines market is anticipated to reach nearly US$ 1.5 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together...

  • Vaccine
  • Market Size
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.
  • Rabies Vaccine or Hydrophobia Vaccine
  • Kinds of Vaccines

This study focuses on China’s Metal Finishing Chemicals industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of...

  • Vaccine
  • China
  • Demand
  • Market Size
  • Supply
  • 7.1 TRANSFORMATION OF VACCINE TECHNOLOGIES
  • 8.4 REDUCING THE TIMELINE FOR VACCINE DEVELOPMENT

The influenza vaccine is one of the most lucrative segment of the global vaccines market. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly...

  • Vaccine
  • Forecast
  • Market Size
  • Novartis AG
  • Sanofi S.A.
  • D) Aggregate deal value by molecular target
  • CANCER VACCINES MARKET, GLOBAL, PIPELINE FOR PROPHYLACTIC CANCER VACCINES BY STAGE OF

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19 Summary Cancer is anticipated to become increasingly prevalent due to aging populations and rising levels of obesity in the developed world. Cancer vaccines...

  • Vaccine
  • World
  • Market Size
  • Juno Therapeutics Inc.
  • Merck & Co., Inc.
  • Intranasal vaccines
  • Intradermal vaccines

About Human Vaccine According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administered by mouth...

  • Vaccine
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi S.A.

Global Markets for Vaccine Technologies Chapter ## Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report Information Sources Methodology Information Sources Geographic Breakdown Analyst’s Credentials Related BCC Research Reports Chapter ## Summary and H

  • Therapy
  • Vaccine
  • World